Advertisement

Radiation Protection by Exogenous Arachidonic Acid and Several Metabolites

  • W. R. Hanson

Abstract

Based on the observations that 16, 16-dimethyl prostaglandin E2 (dm PGE2) protected intestinal clonogenic cells (ICC) from some degree of radiation injury, studies were done to see if exogenous arachidonic acid (AA) and its products were radioprotectants. One mg AA was required to measure protection that increased ICC survival from a single dose of 15.0 Gy cesium-137 from about 9 to 21 cells per jejunal circumference (P < 0.001). With phospholipase A2, lower doses of AA were protective. All prostaglandins (PG’s) were protective with the exception of E1. PGI2 was the most protective natural PG (300% increase in survival), and 15-deoxy, 16-hydroxy,16-methyl PGE1 (misoprostol) was the most protective to date (600% over controls). 16, 16-dm PGE2 also protected ICC from some degree of injury by the high-energy neutrons of Fermilab. Of the leukotrienes (LT’s) tested, LTC4 was the most protective (about 250% above controls) and LTD4 was next in order (150% increase in survival). These results suggest that AA and products of the AA cascade can modify the response of tissue to radiation, which may have both mechanistic and clinical implications.

Keywords

Arachidonic Acid Radiation Protection Radiation Injury Arachidonic Acid Cascade Cell Survival Curve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Prasad, K. N. Radioprotective effect of prostaglandin and an inhibitor of cyclic nucleotide phosphodiesterase on mammalian cells in culture. Int. J. Radiat. Biol. 22: 187–189, 1972.Google Scholar
  2. 2.
    Lehnert, S. Modification of postirradiation survival of mammalian cells by intracellular cyclic AMP. Radiat. Res. 62: 107–116, 1975.PubMedCrossRefGoogle Scholar
  3. 3.
    Hanson, W. R., and Thomas, C. 16-16 dimethyl prostaglandin E2 increases survival of murine intestinal stem cells when given before photon radiation. Radiat. Res. 96: 393–398, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    Hanson, W. R., and Ainsworth, E. J. 16-16 dimethyl prostaglandin E2 induces radioprotection in murine intestinal and hematopoietic stem cells. Radiat. Res. 103: 196–203, 1985.PubMedCrossRefGoogle Scholar
  5. 5.
    Waiden, T. L., Jr., Patchen M., and Snyder, S. L. 16, 16-dimethyl prostaglandin E2 increases survival in mice following irradiation. Rad. Res. (in press).Google Scholar
  6. 6.
    Withers, H. R., and Elkind, M. M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. Radiat. Biol. 17: 261–267, 1970.CrossRefGoogle Scholar
  7. 7.
    Cohen, L., and Awschalom, M. The cancer therapy facility at Fermi National Acclerator Laboratory, Batavia, Illinois: A preliminary report. Appl. Radiol. 5: 51–60, 1976.Google Scholar
  8. 8.
    Hanson, W. R., and DeLaruentiis, K. Comparison of in vivo murine intestinal radiation protection by the E-series prostaglandins; E1, E2, 16-16 dm E2, and Misoprostol. (Submitted to Prostaglandins).Google Scholar
  9. 9.
    Lands, W. E. M. The biosynthesis and metabolism of prostaglandins. Ann. Rev. Physiol. 41: 633–652, 1979.CrossRefGoogle Scholar
  10. 10.
    Samuelsson, B. Prostaglandins, thromboxanes and leukotrienes: Biochemical pathways. In: “Prostaglandins and Cancer: First International Conference.” T. J. Powles, R. S. Bockman, K. V. Honn, and P. Ramwell, eds. Alan R. Liss, Inc., New York, 1982, pp. 1–19.Google Scholar
  11. 11.
    Kuehl, F. A., Jr., and Hunes, J. L. Direct evidence for a prostaglandin receptor and its application to prostaglandin measurements. Proc. Nat. Acad. Sci., U.S.A. 69: 480–491, 1972.CrossRefGoogle Scholar
  12. 12.
    Waiden, T. L., Jr., Holahan, E. V., Jr., and Catravas, G. N. Development of a model system to study leukotriene-induced modification of radiation sensitivity in mammalian cells. Progr. Lipid Res. 25: 587–590, 1986.CrossRefGoogle Scholar
  13. 13.
    Sigdestad, C. P., Grdina, D. J., Connor, A. M., and Hanson, W. R. A comparison of radioprotection from three neutron sources and Cobalt-60 by WR-2721 and WR-151327. Radiat. Res. 106: 224–233, 1986.PubMedCrossRefGoogle Scholar
  14. 14.
    Eisen, V., and Walker, D. I. Effect of ionizing radiation on prostaglandinlike activity in tissues. Br. J. Pharmac. 57: 527–532, 1976.Google Scholar
  15. 15.
    Pausescu, E., Chirvasie, R., Teodosiu, T., and Paun, C. Effects of 60-Co gamma radiation of the hepatic and cerebral levels of some prostaglandins. Radiat. Res. 65: 163–171, 1976.PubMedCrossRefGoogle Scholar
  16. 16.
    Trocha, P. J., and Catravas, G. N. Prostaglandin levels and lysosomal enzyme activities in irradiated rats. Int. J. Radiat. Biol. 38: 503–515, 1980.CrossRefGoogle Scholar
  17. 17.
    Steel, L. K., and Catravas, G. N. Radiation-induced changes in production of prostaglandins F E, and thromboxane B2 in guinea pig parenchymal lung tissues. Int. J. Radiat. Biol. 42: 517–530, 1982.CrossRefGoogle Scholar
  18. 18.
    Yuhas, J. M., and Storer, J. B. Differential chemoprotection of normal and malignant tissues. J. Natl. Cancer Inst. 42: 331–342, 1969.PubMedGoogle Scholar
  19. 19.
    Seyberth, H. W., Segre, G. V., Morgan, J. L., Sweetman, B. J., Potts, J. T., Jr., and Oates, J. A. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N. Engl. J. Med. 293: 1278–1283, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    Cummings, K. B., and Robertson, R. P. Prostaglandin: Increased production by renal cell carcinoma. J. Urol. 118: 720–723, 1977.PubMedGoogle Scholar
  21. 21.
    Prowles, T. J., Coombes, R. C., Neville, A. M., Ford, H. T., Gazet, J. C., and Levine, L. 15-Keto-13,14-dihydroprostaglandin E2 concentrations in serum of patients with breast cancer. Lancet 2: 138–142, 1977.CrossRefGoogle Scholar
  22. 22.
    Bennett, A., Charlier, E. M., McDonald, A. M., Simpson, J. S., Stamford, I. F., and Zebro, T. Prostaglandins and breast cancer. Lancet 2: 624–626, 1977.PubMedCrossRefGoogle Scholar
  23. 23.
    Bennett, A., Carroll, M. A., Stamford, I. F., Whimster W. F., and Williams, F. Prostaglandins and human lung carcinomas. Br. J. Cancer 46: 888–893, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • W. R. Hanson
    • 1
  1. 1.Department of Therapeutic RadiologyRush-Presbyterian-St. Luke’s Medical CenterChicagoUSA

Personalised recommendations